Adaptimmune Therapeutics shares owned by TD Waterhouse Canada
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by TD Waterhouse Canada
from 13F filings
Historical chart of TD Waterhouse Canada investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by TD Waterhouse Canada
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2 | 14 | 0.14 |
| 2025-06-30 | $3 | 14 | 0.21 |
| 2025-03-31 | $3 | 14 | 0.29 |
| 2024-12-31 | $7 | 14 | 0.57 |
| 2024-09-30 | $13 | 14 | 0.93 |